Other OTC - Delayed Quote USD

THC Farmaceuticals, Inc. (CBDG)

0.0430 0.0000 (0.00%)
At close: April 22 at 9:35 AM EDT
Key Events
Loading Chart for CBDG
DELL
  • Previous Close 0.0430
  • Open 0.0430
  • Bid --
  • Ask --
  • Day's Range 0.0430 - 0.0430
  • 52 Week Range 0.0002 - 0.0999
  • Volume 300
  • Avg. Volume 607
  • Market Cap (intraday) 7.348M
  • Beta (5Y Monthly) -6.82
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

THC Farmaceuticals, Inc. owns and operates non-financial institution cash-dispensing automated teller machines at third-party owned retail and commercial locations. The company's machines are placed in hotels, stores, bowling alleys, and other high customer traffic areas for small and medium sized businesses. As of June 30, 2015, it had a total of eight machines for public use along the Wasatch Front in the State of Utah. The company was formerly known as City Media, Inc. and changed its name to THC Farmaceuticals, Inc. in February 2015. THC Farmaceuticals, Inc. was founded in 2008 and is based in Scottsdale, Arizona. THC Farmaceuticals, Inc. operates as a subsidiary of Weed Growth Fund, Inc.

www.thcpharmaceuticals.com

--

Full Time Employees

September 30

Fiscal Year Ends

Related News

Performance Overview: CBDG

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CBDG
95.45%
S&P 500
6.92%

1-Year Return

CBDG
3,483.33%
S&P 500
25.26%

3-Year Return

CBDG
86.13%
S&P 500
22.00%

5-Year Return

CBDG
93.81%
S&P 500
74.29%

Compare To: CBDG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CBDG

Valuation Measures

Annual
As of 4/27/2024
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    441.55

  • Enterprise Value/EBITDA

    -117.77

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -4.96%

  • Return on Equity (ttm)

    -14.87%

  • Revenue (ttm)

    18.52k

  • Net Income Avi to Common (ttm)

    -72.47k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    30.55k

  • Total Debt/Equity (mrq)

    67.47%

  • Levered Free Cash Flow (ttm)

    -38.59k

Company Insights: CBDG

People Also Watch